AstraZeneca will list its shares on the New York Stock Exchange, while maintaining its UK headquarters, its main listing on the London Stock Exchange and its tax base, according to Euronews. The Anglo-Swedish pharmaceutical giant stated that it will replace its current American Depositary Receipts (ADRs) on Nasdaq with a…